# Clinical Impact of the IBox As an Early Intervention TooL

Study · id `cardio:ct-nct05112315` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05112315](<https://clinicaltrials.gov/study/NCT05112315>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05112315

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 507 participants.

## Technical summary

Registry record NCT05112315. Randomized; no masking; primary purpose prevention. Start 2022-02-18 (actual); primary completion 2025-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 507 participants (enrolled count; ClinicalTrials.gov record NCT05112315, source copy `cardio:ctgov-nct05112315-2024-10-04`, retrieved 2026-11-18)
- Started: 2022-02-18 (actual) (ClinicalTrials.gov record NCT05112315, source copy `cardio:ctgov-nct05112315-2024-10-04`, retrieved 2026-11-18)
- Primary completion: 2025-02 (anticipated) (ClinicalTrials.gov record NCT05112315, source copy `cardio:ctgov-nct05112315-2024-10-04`, retrieved 2026-11-18)
- Completion: 2025-02 (anticipated) (ClinicalTrials.gov record NCT05112315, source copy `cardio:ctgov-nct05112315-2024-10-04`, retrieved 2026-11-18)
- Countries: Austria; France; Germany; Israel; Spain; United Kingdom (ClinicalTrials.gov record NCT05112315, source copy `cardio:ctgov-nct05112315-2024-10-04`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05112315-2024-10-04`, retrieved 2026-11-18)

## The registry's words

- Brief title: Clinical Impact of the IBox As an Early Intervention TooL
- Condition: Kidney Diseases
- Condition: Kidney Disease, Chronic
- Condition: Kidney Transplant Rejection
- Condition: Kidney Transplant; Complications
- Condition: Kidney Failure
- Condition: Kidney Failure, Chronic
- Condition: Kidney Dysfunction
- Intervention (Device): Predigraft
- Lead sponsor: Predict4Health
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 3639ee55e8613a96e8d8296c6279560b08e47177a10d8f4901f454600a053ded
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
